Literature DB >> 24314185

Morphology of nervous lesion in the spinal cord and bladder of fetal rats with myelomeningocele at different gestational age.

Jian Shen1, Guomin Zhou, Hong Chen, Yunli Bi.   

Abstract

OBJECTIVE: To analyze the development and innervation of bladder smooth muscle and lesions of the spinal cord in fetal rats with meningomyelocele (MMC) at different gestational ages and to investigate interactions between spinal cord lesions and bladder.
METHOD: Each fetus was assigned to the MMC group or the normal group. Each group was further divided into three subgroups by gestational age: E16, E18, and E20 (embryonic days 16, 18, and 20, respectively). α-Actin and neurotubulin-β-III were analyzed in the bladder, and GFAP and VAChT were analyzed in the lumbosacral spinal cord by immunohistochemistry. Photographs were taken to determine the integrated optical density of each sample.
RESULTS: Neurotubulin-β-III was significantly lower in the MMC group than in the normal group at all fetal ages. Abundant α-actin was detected in both groups at all fetal ages. No significant difference was found between the MMC group and the normal group at any fetal age. At E16 and E18, no GFAP-positive astrocyte was detected in the MMC group or the normal group. At E20, numerous GFAP-positive astrocytes were detected in the MMC group, with significant difference from the normal group. VAChT was detected less in the MMC group than in the normal group at all fetal ages with significant differences.
CONCLUSION: Bladder smooth muscle of fetal MMC rat seems morphologically normal in development, while the innervation of the bladder smooth muscle is markedly decreased centrally and peripherally. Astrocytosis appears at a later embryonic stage, which could be a concern in the nerve repair of the spinal cord.
© 2013.

Entities:  

Keywords:  Fetus; Myelomeningocele; Neurogenic bladder dysfunction; Nevous lesion

Mesh:

Substances:

Year:  2013        PMID: 24314185     DOI: 10.1016/j.jpedsurg.2013.08.021

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

Review 1.  Systematic Review of Urologic Outcomes from Tethered Cord Release in Occult Spinal Dysraphism in Children.

Authors:  Jeffrey T White; Derek C Samples; Juan C Prieto; Izabela Tarasiewicz
Journal:  Curr Urol Rep       Date:  2015-11       Impact factor: 3.092

Review 2.  Fetal surgery for myelomeningocele is effective: a critical look at the whys.

Authors:  Martin Meuli; Ueli Moehrlen
Journal:  Pediatr Surg Int       Date:  2014-06-08       Impact factor: 1.827

3.  The Mechanism of Bladder Injury in Fetal Rats With Myelomeningocele.

Authors:  Ying Liu; Li Chen; Yunli Bi; Jian Shen; Hong Chen; Yujie Ma
Journal:  Front Neurol       Date:  2022-06-09       Impact factor: 4.086

Review 4.  New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction.

Authors:  Minoru Miyazato; Katsumi Kadekawa; Takeya Kitta; Naoki Wada; Nobutaka Shimizu; William C de Groat; Lori A Birder; Anthony J Kanai; Seiichi Saito; Naoki Yoshimura
Journal:  Urol Clin North Am       Date:  2017-08       Impact factor: 2.241

5.  In utero repair of fetal rat myelomeningocele affects neuromuscular development in the bladder.

Authors:  Liangfeng Tang; Haijun Zhong; Hong Chen; Jian Shen; Yunli Bi; Xianmin Xiao
Journal:  Exp Ther Med       Date:  2017-08-21       Impact factor: 2.447

6.  In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion.

Authors:  Yushi Abe; Daigo Ochiai; Hirotaka Masuda; Yu Sato; Toshimitsu Otani; Marie Fukutake; Satoru Ikenoue; Kei Miyakoshi; Hideyuki Okano; Mamoru Tanaka
Journal:  Stem Cells Transl Med       Date:  2019-08-13       Impact factor: 6.940

Review 7.  State of the art in translating experimental myelomeningocele research to the bedside.

Authors:  Lourenço Sbragia; Karina Miura da Costa; Antonio Landolffi Abdul Nour; Rodrigo Ruano; Marcelo Volpon Santos; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2021-07-31       Impact factor: 1.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.